PanTera signs agreement with Bayer for the supply of
Agreement demonstrates PanTera’s unique ability to support the radionuclide therapeutics industry in bringing new cancer treatments to patients Mol,...
Stay updated with breaking news from Iba Sa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Agreement demonstrates PanTera’s unique ability to support the radionuclide therapeutics industry in bringing new cancer treatments to patients Mol,...
Highly complementary acquisition continues IBA’s expansion strategy to lead the Radiotherapy, Medical Imaging Dosimetry and Quality Assurance markets...
Louvain-La-Neuve, Belgium, 08 December 2022 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today...
New contract to provide broader access to diagnostics in emerging markets Louvain-La-Neuve, Belgium, October 13, 2022 – IBA (Ion Beam Applications S.A.,...
Louvain-La-Neuve, Belgium, 26 August, 2022 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the...